The first person in the world to receive an mRNA Covid vaccine outside a clinical trial was Margaret Keenan, a 90-year-old Englishwoman, on Dec. 8, 2020.
In the 14 months since, more than 1 billion people worldwide have received more than 2 billion shots of mRNA.
None are in China.
A Chinese pharmaceutical company signed a deal to buy 100 million doses of the Pfizer/BioNTech vaccine a week after that first shot.
None have been given to anyone in China.
But wait!
This delay has a totally innocent explanation. National pride, ya see. The Chinese don’t want to admit they have to buy an American/German shot.
Yep, that’s the ticket.
Here’s the proof. Chinese pharmaceutical companies are also “developing” their own mRNA shot, called ARCoV.
They’re moving fast, too!
How fast.
The Chinese companies finished their preliminary human clinical trial of ARCoV on December 2, 2020. It covered all of 230 people.
Not 2021. 2020. BEFORE Margaret Keenan received her first dose.
14 months have passed since that trial finished.
It is not even clear that those Chinese companies have started human dosing in the larger “Phase 3” clinical trial that would be necessary before China can approve ARCoV. And nobody seems to know when the trial might be done.
1 comment:
They know what an MRNA vaccine will often trigger both at first and down the line?
Post a Comment